Srini Ramanathan
Corporate Officer/Principal bei ROIVANT SCIENCES LTD.
Aktive Positionen von Srini Ramanathan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 02.05.2022 | - |
Karriereverlauf von Srini Ramanathan
Ehemalige bekannte Positionen von Srini Ramanathan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von Srini Ramanathan
| Duquesne University School of Law | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 2 |
| Irland | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Srini Ramanathan
- Erfahrung
